Journal Editors Criticize FDA’s Quick Dismissal Of IOM Advice
This article was originally published in The Gray Sheet
Executive Summary
Editors of two premier peer-reviewed medical journals are calling out FDA for its quick, dismissive response to the Institute of Medicine’s recommendation to replace the 510(k) program.
You may also be interested in...
Split Predicate? Nope, That’s A ‘Reference Device,’ FDA Says
An upcoming FDA guidance will explain how firms can use additional “reference devices” in 510(k) submissions to help reviewers better understand new technologies, the agency says.
Split Predicate? Nope, That’s A ‘Reference Device,’ FDA Says
An upcoming FDA guidance will explain how firms can use additional “reference devices” in 510(k) submissions to help reviewers better understand new technologies, the agency says.
FDA Seeks PMA Requirements For More Pre-Amendment Devices
FDA is proposing to require pre-market approval applications for three class III, pre-amendment device types in the cardiovascular and neurologic device spaces.